Min Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Min Wu has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Bin Liu
Department of Chemical and Biomolecular Engineering National University of Singapore Singapore Singapore
11 shared publications - Guping Tang
Department of Biological Sciences, Michigan Technological University , 1400 Townsend Dr, Houghton, MI 49931
5 shared publications Xingang Liu
Department of Chemical and Biomolecular Engineering National University of Singapore 4 Engineering Drive 4 Singapore 117585 Singapore
5 shared publications- Huan Chen
Center of Super‐Diamond and Advanced Films (COSDAF) Department of Chemistry City University of Hong Kong Kowloon Hong Kong SAR P. R. China
4 shared publications Jingjing Liu
Department of Chemical and Biomolecular Engineering National University of Singapore 4 Engineering Drive 4 Singapore 117585 Singapore
3 shared publicationsMeng Wang
Department of Hepatobiliary and Pancreatic Surgery First Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310003 P. R. China
3 shared publications
Latest Publications
- Open Access
- 17 August 2026
- Published by Wiley in Advanced Science
- Vol. 13 (62)
Sunscreen‐Inspired Nano‐Pesticide for UV‐Shielding and Laccase‐Responsive Delivery of Mancozeb With Enhanced Fungicidal Efficacy and Ecological Safety
Fungicides are a crucial tool for protecting crops and ensuring consistent food supply. As a fundamental and widely‐used fungicide in global agriculture, mancozeb (MCB) suffers from rapid photodegradation, poor foliar adhesion, and substantial non‐target toxicity, limiting its efficacy and environmental compatibility. To address these issues, we developed a sunscreen‐inspired nano‐pesticide, MCB@URFSL, designed to enhance MCB's photostability, rainfastness, and targeted delivery. This system was fabricated via the co‐assembly of phthalate‐modified Pluronic F127 (URF) and lignosulfonate (SL), yielding monodisperse nanoparticles (∼180 nm) with integrated UV‐shielding, laccase‐responsive, and pathogen‐targeting properties. The strategy significantly improved MCB's photostability, retaining over 60% of antifungal activity after 5 days of UVA exposure. MCB@URFSL exhibited enhanced leaf adhesion and rainfastness on tomato leaves, along with laccase‐triggered release. In vitro and in vivo bioassays confirmed its superior protective and curative efficacy against fungal infections in cucumber seedlings. Importantly, the nanocarrier significantly reduced MCB's toxicity toward human keratinocytes, Escherichia coli , and zebrafish, with no acute mortality observed even at a concentration of 50 µg/mL. This work presents an intelligent nano‐pesticide strategy that synergistically enhances fungicidal efficacy and ecological safety, thereby establishing a promising platform for pioneering the next generation of agrochemicals.
- 17 August 2026
- Published by Wiley in Advanced Science
- Vol. 13 (62)
Open AccessSunscreen‐Inspired Nano‐Pesticide for UV‐Shielding and Laccase‐Responsive Delivery of Mancozeb With Enhanced Fungicidal Efficacy and Ecological Safety
Fungicides are a crucial tool for protecting crops and ensuring consistent food supply. As a fundamental and widely‐used fungicide in global agriculture, mancozeb (MCB) suffers from rapid photodegradation, poor foliar adhesion, and substantial non‐target toxicity, limiting its efficacy and environmental compatibility. To address these issues, we developed a sunscreen‐inspired nano‐pesticide, MCB@URFSL, designed to enhance MCB's photostability, rainfastness, and targeted delivery. This system was fabricated via the co‐assembly of phthalate‐modified Pluronic F127 (URF) and lignosulfonate (SL), yielding monodisperse nanoparticles (∼180 nm) with integrated UV‐shielding, laccase‐responsive, and pathogen‐targeting properties. The strategy significantly improved MCB's photostability, retaining over 60% of antifungal activity after 5 days of UVA exposure. MCB@URFSL exhibited enhanced leaf adhesion and rainfastness on tomato leaves, along with laccase‐triggered release. In vitro and in vivo bioassays confirmed its superior protective and curative efficacy against fungal infections in cucumber seedlings. Importantly, the nanocarrier significantly reduced MCB's toxicity toward human keratinocytes, Escherichia coli , and zebrafish, with no acute mortality observed even at a concentration of 50 µg/mL. This work presents an intelligent nano‐pesticide strategy that synergistically enhances fungicidal efficacy and ecological safety, thereby establishing a promising platform for pioneering the next generation of agrochemicals.
- 10 April 2024
- Published by Wiley in Advanced Materials
- Vol. 36 (25) , e2401017
X‐Ray‐Triggered CO‐Release from Gold Nanocluster: All‐in‐One Nanoplatforms for Cancer Targeted Gas and Radio Synergistic Therapy
Glycolysis‐dominant metabolic pathway in cancer cells can promote their therapeutic resistance against radiotherapy (RT). Carbon monoxide (CO) as a glycolysis inhibitor can enhance the efficiency of RT. Herein, an X‐ray responsive CO‐releasing nanocomposite (HA@AuNC@CO) based on strong host–guest interactions between the radiosensitizer and CO donor for enhanced RT is developed. The encapsulated gold nanoclusters (CD‐AuNCs) can effectively generate cytotoxic reactive oxygen species (ROS) under X‐ray radiation, which not only directly inactivate cancer cells but also induce in situ CO gas generation from adamantane modified metal carbonyl (Ada‐CO) for glycolysis inhibition. Both in vitro and in vivo results demonstrate that HA@AuNC@CO exhibits active targeting toward CD44 overexpressed cancer cells, along with excellent inhibition of glycolysis and efficient RT against cancer. This study offers a new strategy for the combination of gas therapy and RT in tumor treatment.
- 10 April 2024
- Published by Wiley in Advanced Materials
- Vol. 36 (25) , e2401017
X‐Ray‐Triggered CO‐Release from Gold Nanocluster: All‐in‐One Nanoplatforms for Cancer Targeted Gas and Radio Synergistic Therapy
Glycolysis‐dominant metabolic pathway in cancer cells can promote their therapeutic resistance against radiotherapy (RT). Carbon monoxide (CO) as a glycolysis inhibitor can enhance the efficiency of RT. Herein, an X‐ray responsive CO‐releasing nanocomposite (HA@AuNC@CO) based on strong host–guest interactions between the radiosensitizer and CO donor for enhanced RT is developed. The encapsulated gold nanoclusters (CD‐AuNCs) can effectively generate cytotoxic reactive oxygen species (ROS) under X‐ray radiation, which not only directly inactivate cancer cells but also induce in situ CO gas generation from adamantane modified metal carbonyl (Ada‐CO) for glycolysis inhibition. Both in vitro and in vivo results demonstrate that HA@AuNC@CO exhibits active targeting toward CD44 overexpressed cancer cells, along with excellent inhibition of glycolysis and efficient RT against cancer. This study offers a new strategy for the combination of gas therapy and RT in tumor treatment.
- 19 July 2023
- Published by Elsevier in Biomaterials
- Vol. 301, 122248
Organic functional substance engineered living materials for biomedical applications
- 19 July 2023
- Published by Elsevier in Biomaterials
- Vol. 301, 122248
Organic functional substance engineered living materials for biomedical applications
- Open Access
- 18 August 2022
- Published by Wiley in Advanced Science
- Vol. 9 (29) , e2202914
Pyroptosis Remodeling Tumor Microenvironment to Enhance Pancreatic Cancer Immunotherapy Driven by Membrane Anchoring Photosensitizer
Immunotherapy, the most promising strategy of cancer treatment, has achieved promising outcomes, but its clinical efficacy in pancreatic cancer is limited mainly due to the complicated tumor immunosuppressive microenvironment. As a highly inflammatory form of immunogenic cell death (ICD), pyroptosis provides a great opportunity to alleviate immunosuppression and promote systemic immune responses in solid tumors. Herein, membrane‐targeted photosensitizer TBD‐3C with aggregation‐induced emission (AIE) feature to trigger pyroptosis‐aroused cancer immunotherapy via photodynamic therapy (PDT) is applied. The results reveal that pyroptotic cells induced by TBD‐3C could stimulate M1‐polarization of macrophages, cause maturation of dendritic cells (DCs), and activation of CD8+ cytotoxic T‐lymphocytes (CTLs). Pyroptosis‐aroused immunological responses could convert immunosuppressive “cold” tumor microenvironment (TME) to immunogenic “hot” TME, which not only inhibits primary pancreatic cancer growth but also attacks the distant tumor. This work establishes a platform with high biocompatibility for light‐controlled antitumor immunity and solid tumor immunotherapy aroused by cell pyroptosis.
- 18 August 2022
- Published by Wiley in Advanced Science
- Vol. 9 (29) , e2202914
Open AccessPyroptosis Remodeling Tumor Microenvironment to Enhance Pancreatic Cancer Immunotherapy Driven by Membrane Anchoring Photosensitizer
Immunotherapy, the most promising strategy of cancer treatment, has achieved promising outcomes, but its clinical efficacy in pancreatic cancer is limited mainly due to the complicated tumor immunosuppressive microenvironment. As a highly inflammatory form of immunogenic cell death (ICD), pyroptosis provides a great opportunity to alleviate immunosuppression and promote systemic immune responses in solid tumors. Herein, membrane‐targeted photosensitizer TBD‐3C with aggregation‐induced emission (AIE) feature to trigger pyroptosis‐aroused cancer immunotherapy via photodynamic therapy (PDT) is applied. The results reveal that pyroptotic cells induced by TBD‐3C could stimulate M1‐polarization of macrophages, cause maturation of dendritic cells (DCs), and activation of CD8+ cytotoxic T‐lymphocytes (CTLs). Pyroptosis‐aroused immunological responses could convert immunosuppressive “cold” tumor microenvironment (TME) to immunogenic “hot” TME, which not only inhibits primary pancreatic cancer growth but also attacks the distant tumor. This work establishes a platform with high biocompatibility for light‐controlled antitumor immunity and solid tumor immunotherapy aroused by cell pyroptosis.
- 25 January 2022
- Published by Wiley in Advanced Materials
- Vol. 34 (13) , 2109010
Direct Synthesis of Photosensitizable Bacterial Cellulose as Engineered Living Material for Skin Wound Repair
Living materials based on bacterial cellulose (BC) represent a natural and promising candidate for wound dressing. Both physical adsorption and chemical methods have been applied to BC for realizing antibacterial function. However, effective and long‐lasting incorporation of bactericidal moieties to BC remains challenging. Herein, a Komagataeibacter sucrofermentans‐based direct synthetic method to fabricate photosensitizer‐grafted BC through in situ bacterial metabolism in the presence of TPEPy‐modified glucose is explored. The results verify that the direct biosynthesis method is efficient and convenient to endow BC with outstanding fluorescence and light‐triggered photodynamic bactericidal activity for skin wound repair. This work presents a new approach to fabricate eco‐friendly and active wound dressing with light‐controlled bactericidal activity by microbial metabolism. The successful modification of the glucose carbon source of microorganisms also offers insights for biosyntheses of other living materials through microbial metabolism.
- 25 January 2022
- Published by Wiley in Advanced Materials
- Vol. 34 (13) , 2109010
Direct Synthesis of Photosensitizable Bacterial Cellulose as Engineered Living Material for Skin Wound Repair
Living materials based on bacterial cellulose (BC) represent a natural and promising candidate for wound dressing. Both physical adsorption and chemical methods have been applied to BC for realizing antibacterial function. However, effective and long‐lasting incorporation of bactericidal moieties to BC remains challenging. Herein, a Komagataeibacter sucrofermentans‐based direct synthetic method to fabricate photosensitizer‐grafted BC through in situ bacterial metabolism in the presence of TPEPy‐modified glucose is explored. The results verify that the direct biosynthesis method is efficient and convenient to endow BC with outstanding fluorescence and light‐triggered photodynamic bactericidal activity for skin wound repair. This work presents a new approach to fabricate eco‐friendly and active wound dressing with light‐controlled bactericidal activity by microbial metabolism. The successful modification of the glucose carbon source of microorganisms also offers insights for biosyntheses of other living materials through microbial metabolism.
- 4 February 2021
- Published by Wiley in Angewandte Chemie
- Vol. 133 (16) , 9175-9180
Activation of Pyroptosis by Membrane‐Anchoring AIE Photosensitizer Design: New Prospect for Photodynamic Cancer Cell Ablation
Pyroptosis as a lytic and inflammatory form of cell death is a powerful tool to fight against cancer. However, pyroptosis is usually activated by chemotherapeutic drugs, which limits its anti‐tumor applications due to drug resistance and severe side effects. Herein, we demonstrate that membrane targeting photosensitizers can induce pyroptosis for cancer cell ablation with noninvasiveness and low side effects. A series of membrane anchoring photosensitizers (TBD‐R PSs) with aggregation‐induced emission (AIE) characteristics were prepared through conjugation of TBD and phenyl ring with cationic chains. Upon light irradiation, cytotoxic ROS were produced in situ, resulting in direct membrane damage and superior cancer cell ablation. Detailed study revealed that pyroptosis gradually became the dominant cell death pathway along with the increase of TBD‐R PSs membrane anchoring capability. This study offers a photo‐activated pyroptosis‐based intervention strategy for cancer cell ablation.
- 4 February 2021
- Published by Wiley in Angewandte Chemie
- Vol. 133 (16) , 9175-9180
Activation of Pyroptosis by Membrane‐Anchoring AIE Photosensitizer Design: New Prospect for Photodynamic Cancer Cell Ablation
Pyroptosis as a lytic and inflammatory form of cell death is a powerful tool to fight against cancer. However, pyroptosis is usually activated by chemotherapeutic drugs, which limits its anti‐tumor applications due to drug resistance and severe side effects. Herein, we demonstrate that membrane targeting photosensitizers can induce pyroptosis for cancer cell ablation with noninvasiveness and low side effects. A series of membrane anchoring photosensitizers (TBD‐R PSs) with aggregation‐induced emission (AIE) characteristics were prepared through conjugation of TBD and phenyl ring with cationic chains. Upon light irradiation, cytotoxic ROS were produced in situ, resulting in direct membrane damage and superior cancer cell ablation. Detailed study revealed that pyroptosis gradually became the dominant cell death pathway along with the increase of TBD‐R PSs membrane anchoring capability. This study offers a photo‐activated pyroptosis‐based intervention strategy for cancer cell ablation.
- Top Cited Papers
- 4 February 2021
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 60 (16) , 9093-9098
Activation of Pyroptosis by Membrane‐Anchoring AIE Photosensitizer Design: New Prospect for Photodynamic Cancer Cell Ablation
Pyroptosis as a lytic and inflammatory form of cell death is a powerful tool to fight against cancer. However, pyroptosis is usually activated by chemotherapeutic drugs, which limits its anti‐tumor applications due to drug resistance and severe side effects. Herein, we demonstrate that membrane targeting photosensitizers can induce pyroptosis for cancer cell ablation with noninvasiveness and low side effects. A series of membrane anchoring photosensitizers (TBD‐R PSs) with aggregation‐induced emission (AIE) characteristics were prepared through conjugation of TBD and phenyl ring with cationic chains. Upon light irradiation, cytotoxic ROS were produced in situ, resulting in direct membrane damage and superior cancer cell ablation. Detailed study revealed that pyroptosis gradually became the dominant cell death pathway along with the increase of TBD‐R PSs membrane anchoring capability. This study offers a photo‐activated pyroptosis‐based intervention strategy for cancer cell ablation.
- 4 February 2021
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 60 (16) , 9093-9098
Top Cited PapersActivation of Pyroptosis by Membrane‐Anchoring AIE Photosensitizer Design: New Prospect for Photodynamic Cancer Cell Ablation
Pyroptosis as a lytic and inflammatory form of cell death is a powerful tool to fight against cancer. However, pyroptosis is usually activated by chemotherapeutic drugs, which limits its anti‐tumor applications due to drug resistance and severe side effects. Herein, we demonstrate that membrane targeting photosensitizers can induce pyroptosis for cancer cell ablation with noninvasiveness and low side effects. A series of membrane anchoring photosensitizers (TBD‐R PSs) with aggregation‐induced emission (AIE) characteristics were prepared through conjugation of TBD and phenyl ring with cationic chains. Upon light irradiation, cytotoxic ROS were produced in situ, resulting in direct membrane damage and superior cancer cell ablation. Detailed study revealed that pyroptosis gradually became the dominant cell death pathway along with the increase of TBD‐R PSs membrane anchoring capability. This study offers a photo‐activated pyroptosis‐based intervention strategy for cancer cell ablation.
- 20 October 2020
- Published by Wiley in Advanced Materials
- Vol. 32 (47) , e2005222
HClO‐Activated Fluorescence and Photosensitization from an AIE Nanoprobe for Image‐Guided Bacterial Ablation in Phagocytes
Bacteria hiding in host phagocytes are difficult to kill, which can cause phagocyte disorders resulting in local and systemic tissue damage. Effective accumulation of activatable photosensitizers (PSs) in phagocytes to realize selective imaging and on‐demand photodynamic ablation of bacteria is of great scientific and practical interests for precise bacteria diagnosis and treatment. Herein, HClO‐activatable theranostic nanoprobes, DTF‐FFP NPs, for image‐guided bacterial ablation in phagocytes are introduced. DTF‐FFP NPs are prepared by nanoprecipitation of an HClO‐responsive near‐infrared molecule FFP and an efficient PS DTF with aggregation‐induced emission characteristic using an amphiphilic polymer Pluronic F127 as the encapsulation matrix. As an energy acceptor, FFP can quench both fluorescence and production of reactive oxygen species (ROS) of DTF, thus eliminating the phototoxicity of DTF‐FFP NPs in normal cells and tissues. Once delivered to the infection sites, DTF‐FFP NPs light up with red fluorescence and efficiently generate ROS owing to the degradation of FFP by the stimulated release of HClO in phagocytes. The selective activation of fluorescence and photosensitization is successfully confirmed by both in vitro and in vivo results, demonstrating the effectiveness and theranostic potential of DTF‐FFP NPs in precise bacterial therapy.
- 20 October 2020
- Published by Wiley in Advanced Materials
- Vol. 32 (47) , e2005222
HClO‐Activated Fluorescence and Photosensitization from an AIE Nanoprobe for Image‐Guided Bacterial Ablation in Phagocytes
Bacteria hiding in host phagocytes are difficult to kill, which can cause phagocyte disorders resulting in local and systemic tissue damage. Effective accumulation of activatable photosensitizers (PSs) in phagocytes to realize selective imaging and on‐demand photodynamic ablation of bacteria is of great scientific and practical interests for precise bacteria diagnosis and treatment. Herein, HClO‐activatable theranostic nanoprobes, DTF‐FFP NPs, for image‐guided bacterial ablation in phagocytes are introduced. DTF‐FFP NPs are prepared by nanoprecipitation of an HClO‐responsive near‐infrared molecule FFP and an efficient PS DTF with aggregation‐induced emission characteristic using an amphiphilic polymer Pluronic F127 as the encapsulation matrix. As an energy acceptor, FFP can quench both fluorescence and production of reactive oxygen species (ROS) of DTF, thus eliminating the phototoxicity of DTF‐FFP NPs in normal cells and tissues. Once delivered to the infection sites, DTF‐FFP NPs light up with red fluorescence and efficiently generate ROS owing to the degradation of FFP by the stimulated release of HClO in phagocytes. The selective activation of fluorescence and photosensitization is successfully confirmed by both in vitro and in vivo results, demonstrating the effectiveness and theranostic potential of DTF‐FFP NPs in precise bacterial therapy.
- 20 December 2019
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 20 (1) , 11-21
Bioengineering Bacterial Vesicle-Coated Polymeric Nanomedicine for Enhanced Cancer Immunotherapy and Metastasis Prevention
We herein propose a bioengineering approach where bacterial outer membrane vesicles (OMVs) were coated on drug-loaded polymeric micelles to generate an innovative nanomedicine for effective cancer immunotherapy and metastasis prevention. Whereas OMVs could activate the host immune response for cancer immunotherapy, the loaded drug within polymeric micelles would exert both chemotherapeutic and immunomodulatory roles to sensitize cancer cells to cytotoxic T lymphocytes (CTLs) and to kill cancer cells directly. We demonstrated that the systemic injection of such a bioinspired immunotherapeutic agent would not only provide effective protective immunity against melanoma occurrence but also significantly inhibited tumor growth in vivo and extended the survival rate of melanoma mice. Importantly, the nanomedicine could also effectively inhibit tumor metastasis to the lung. The bioinspired immunomodulatory nanomedicine we have developed repurposes the bacterial-based formulation for cancer immunotherapy, which also defines a useful bioengineering strategy to the improve current cancer immunotherapeutic agents and delivery systems.
- 20 December 2019
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 20 (1) , 11-21
Bioengineering Bacterial Vesicle-Coated Polymeric Nanomedicine for Enhanced Cancer Immunotherapy and Metastasis Prevention
We herein propose a bioengineering approach where bacterial outer membrane vesicles (OMVs) were coated on drug-loaded polymeric micelles to generate an innovative nanomedicine for effective cancer immunotherapy and metastasis prevention. Whereas OMVs could activate the host immune response for cancer immunotherapy, the loaded drug within polymeric micelles would exert both chemotherapeutic and immunomodulatory roles to sensitize cancer cells to cytotoxic T lymphocytes (CTLs) and to kill cancer cells directly. We demonstrated that the systemic injection of such a bioinspired immunotherapeutic agent would not only provide effective protective immunity against melanoma occurrence but also significantly inhibited tumor growth in vivo and extended the survival rate of melanoma mice. Importantly, the nanomedicine could also effectively inhibit tumor metastasis to the lung. The bioinspired immunomodulatory nanomedicine we have developed repurposes the bacterial-based formulation for cancer immunotherapy, which also defines a useful bioengineering strategy to the improve current cancer immunotherapeutic agents and delivery systems.
- 31 October 2019
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 59 (2) , 632-636
Membrane‐Anchoring Photosensitizer with Aggregation‐Induced Emission Characteristics for Combating Multidrug‐Resistant Bacteria
Traditional photosensitizers (PSs) show reduced singlet oxygen (1O2) production and quenched fluorescence upon aggregation in aqueous media, which greatly affect their efficiency in photodynamic therapy (PDT). Meanwhile, non‐targeting PSs generally yield low efficiency in antibacterial performance due to their short lifetimes and small effective working radii. Herein, a water‐dispersible membrane anchor (TBD‐anchor) PS with aggregation‐induced emission is designed and synthesized to generate 1O2 on the bacterial membrane. TBD‐anchor showed efficient antibacterial performance towards both Gram‐negative (Escherichia coli) and Gram‐positive bacteria (Staphylococcus aureus). Over 99.8 % killing efficiency was obtained for methicillin‐resistant S. aureus (MRSA) when they were exposed to 0.8 μm of TBD‐anchor at a low white light dose (25 mW cm−2) for 10 minutes. TBD‐anchor thus shows great promise as an effective antimicrobial agent to combat the menace of multidrug‐resistant bacteria.
- 31 October 2019
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 59 (2) , 632-636
Membrane‐Anchoring Photosensitizer with Aggregation‐Induced Emission Characteristics for Combating Multidrug‐Resistant Bacteria
Traditional photosensitizers (PSs) show reduced singlet oxygen (1O2) production and quenched fluorescence upon aggregation in aqueous media, which greatly affect their efficiency in photodynamic therapy (PDT). Meanwhile, non‐targeting PSs generally yield low efficiency in antibacterial performance due to their short lifetimes and small effective working radii. Herein, a water‐dispersible membrane anchor (TBD‐anchor) PS with aggregation‐induced emission is designed and synthesized to generate 1O2 on the bacterial membrane. TBD‐anchor showed efficient antibacterial performance towards both Gram‐negative (Escherichia coli) and Gram‐positive bacteria (Staphylococcus aureus). Over 99.8 % killing efficiency was obtained for methicillin‐resistant S. aureus (MRSA) when they were exposed to 0.8 μm of TBD‐anchor at a low white light dose (25 mW cm−2) for 10 minutes. TBD‐anchor thus shows great promise as an effective antimicrobial agent to combat the menace of multidrug‐resistant bacteria.